Literature DB >> 10405152

Human hepatitis B virus mutants: significance of molecular changes.

W N Chen1, C J Oon.   

Abstract

Human hepatitis B virus, the leading pathogen for hepatitis B, is a compact DNA virus with viral genes that largely overlap. An increasing number of mutations have emerged following human interventions such as vaccination and anti-viral therapy. While vaccine escape mutants are characterized by mutations on the antigenic hepatitis B surface antigen, those carrying mutations in other viral proteins are either resistant to anti-viral therapy or implicated in acute liver diseases. Molecular identification of these various mutants should shed new lights on the underlying mechanism of hepatitis B virus viral escape and resistance and provide helpful information on their effective eradication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405152     DOI: 10.1016/s0014-5793(99)00704-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Horizontal transmission of a hepatitis B virus surface antigen mutant.

Authors:  W N Chen; C J Oon; S Koh
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Changes in the antigenicity of a hepatitis B virus mutant stemming from lamivudine therapy.

Authors:  W N Chen; C J Oon
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Hepatitis B virus X protein in the proteasome of mammalian cells: defining the targeting domain.

Authors:  W N Chen; C J Oon; K S Goo
Journal:  Mol Biol Rep       Date:  2001-03       Impact factor: 2.316

4.  Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg.

Authors:  W N Chen; C J Oon
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Precore mutant hepatitis B virus-associated fulminant hepatitis during infliximab therapy for rheumatoid arthritis.

Authors:  Hiroko Kuwabara; Akira Fukuda; Yasuhiro Tsuda; Yuro Shibayama
Journal:  Clin Rheumatol       Date:  2010-04-09       Impact factor: 2.980

6.  Identification of cellular membrane proteins interacting with hepatitis B surface antigen using yeast split-ubiquitin system.

Authors:  Qi Chun Toh; Tuan Lin Tan; Wei Qiang Teo; Chin Yee Ho; Subhajeet Parida; Wei Ning Chen
Journal:  Int J Med Sci       Date:  2005-07-05       Impact factor: 3.738

7.  DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes.

Authors:  Dandan Niu; Huixing Feng; Wei Ning Chen
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

8.  Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.

Authors:  Yu-Heng Lai; Cheng-Pu Sun; Hsiu-Chen Huang; Jui-Chieh Chen; Hui-Kang Liu; Cheng Huang
Journal:  BMC Complement Altern Med       Date:  2018-09-06       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.